mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |